Copyright © Inderes 2011 - present. All rights reserved.

Vimian Group

42.85

 

SEK

 

+1.18 %

VIMIAN

First North Stockholm

Health Care Providers

Health Care

5 following
+1.18%
+2.63%
+9.45%
+26.78%
+49.51%
+78.3%
-56.23%
-
-45.3%
vimian.com/investors

Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.

Revenue
3.69B
EBIT %
12.44 %
P/E
192.43
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
VIMIAN
Daily low / high price
42.5 / 43.35 SEK
Market cap
22.45B SEK
Turnover
6.44M SEK
Volume
151K

Latest videos

Vimian Group, Audiocast with teleconference, Q3'24
2024-10-24
Vimian Group, Audiocast with teleconference, Q2'24
2024-08-15
Vimian Group, Investor Day, 2024
2024-05-22

Financial calendar

Annual report
2025-02-13
Interim report
2025-04-29
General meeting
2025-04-29
Interim report
2025-07-18
Interim report
2025-10-22

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Fidelio Vet Holding56.9 %57.4 %
Handelsbanken Funds3.8 %3.8 %
PRG Investment Holdings3.4 %3.6 %
Capital Group2.4 %2.4 %
Swedbank Robur Funds1.9 %1.9 %
Finn Pharmaceuticals Trust1.7 %1.7 %
SEB Funds1.5 %1.5 %
Fourth Swedish National Pension Fund1.2 %1.2 %
Investering & Tryghed A/S1.2 %1.2 %
Avanza Pension1.2 %1.2 %
Login in to make your own estimates and see other investors estimates.
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account